Ruffer LLP grew its holdings in shares of Endava PLC Sponsored ADR (NYSE:DAVA - Free Report) by 60.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 209,187 shares of the company's stock after acquiring an additional 78,870 shares during the period. Ruffer LLP owned about 0.35% of Endava worth $3,205,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors also recently modified their holdings of the company. M&T Bank Corp lifted its stake in Endava by 182.3% in the 1st quarter. M&T Bank Corp now owns 39,499 shares of the company's stock worth $770,000 after purchasing an additional 25,506 shares in the last quarter. Trexquant Investment LP bought a new position in Endava in the 1st quarter worth about $764,000. Two Sigma Investments LP boosted its stake in shares of Endava by 165.0% during the fourth quarter. Two Sigma Investments LP now owns 59,089 shares of the company's stock valued at $1,826,000 after purchasing an additional 36,789 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Endava by 1,029.1% during the first quarter. GAMMA Investing LLC now owns 18,144 shares of the company's stock valued at $354,000 after purchasing an additional 16,537 shares in the last quarter. Finally, Janney Montgomery Scott LLC boosted its stake in shares of Endava by 85.9% during the first quarter. Janney Montgomery Scott LLC now owns 47,125 shares of the company's stock valued at $919,000 after purchasing an additional 21,773 shares in the last quarter. Hedge funds and other institutional investors own 62.23% of the company's stock.
Endava Trading Up 2.2%
Shares of NYSE:DAVA opened at $9.38 on Thursday. Endava PLC Sponsored ADR has a 52 week low of $9.10 and a 52 week high of $34.94. The company's 50 day moving average is $12.31 and its two-hundred day moving average is $15.56. The company has a current ratio of 2.32, a quick ratio of 2.32 and a debt-to-equity ratio of 0.31. The company has a market cap of $553.42 million, a PE ratio of 20.83 and a beta of 1.13.
Analysts Set New Price Targets
DAVA has been the topic of several analyst reports. Cowen reaffirmed a "hold" rating on shares of Endava in a report on Friday, September 5th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Endava in a report on Thursday, July 17th. They set a "hold" rating and a $14.00 target price for the company. Wall Street Zen cut shares of Endava from a "buy" rating to a "hold" rating in a report on Saturday, August 16th. Needham & Company LLC cut their price objective on shares of Endava from $20.00 to $12.00 and set a "buy" rating for the company in a report on Friday, September 5th. Finally, Guggenheim dropped their target price on shares of Endava from $20.00 to $18.00 and set a "buy" rating on the stock in a research report on Friday, September 5th. Three equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $20.78.
View Our Latest Analysis on DAVA
Endava Company Profile
(
Free Report)
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Endava, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.
While Endava currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.